
Topic
Prior Authorization
Documentation, step edits, renewal cycles, appeals, and how payer criteria shape real-world drug use.

Pricing & Access· June 6, 2026 · 9 min read

Pricing & Access· June 6, 2026 · 10 min read
OptumRx GLP-1 coverage: formulary tiers, PA criteria, and 2026 UM rules
By Ran Chen#GLP-1#OptumRx#Prior Authorization

Pricing & Access· June 6, 2026 · 11 min read
TRICARE GLP-1 coverage: plan breakdown, PA criteria, and August 2025 change
By Ran Chen#GLP-1#TRICARE#Prior Authorization

Pricing & Access· June 6, 2026 · 11 min read
UMR GLP-1 coverage: PA criteria, formulary tiers, and employer-plan rules for 2026
By Ran Chen#GLP-1#UMR#Prior Authorization

Pricing & Access· June 6, 2026 · 12 min read
UnitedHealthcare GLP-1 coverage: PA criteria, reauth rules, and plan variations
By Ran Chen#GLP-1#UnitedHealthcare#UHC

Pricing & Access· June 6, 2026 · 11 min read
VA GLP-1 coverage: formulary status, non-formulary Wegovy criteria, and CHAMPVA rules
By Ran Chen#GLP-1#Veterans Affairs#Prior Authorization

Pricing & Access· June 5, 2026 · 15 min read
Rybelsus coverage guide: oral semaglutide access, formulary tiers, and prior authorization
By Ran Chen#GLP-1#Payer Coverage#Prior Authorization

Policy· June 4, 2026 · 13 min read
Medicare Part D GLP-1 coverage policy and the 2026 Bridge
By Ran Chen#GLP-1#Medicare Part D#Payer Coverage

Pricing & Access· June 4, 2026 · 13 min read
Ozempic prior authorization checklist for 2026
By Ran Chen#GLP-1#Prior Authorization#Payer Coverage

Pricing & Access· June 4, 2026 · 14 min read
TNF inhibitor access landscape: Humira, Enbrel, Remicade, Cimzia, and Simponi in 2026
By Ran Chen#Biosimilars#TNF Inhibitor#Payer Coverage